---
figid: PMC4951124__pone.0159490.g006
figtitle: CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion
  through Non-Canonical EGFR/MEK/ERK Signaling
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Equus caballus
- Homo sapiens
- Human immunodeficiency virus 1
- Raphanus sativus
pmcid: PMC4951124
filename: pone.0159490.g006.jpg
figlink: /pmc/articles/PMC4951124/figure/pone.0159490.g006/
number: F6
caption: The canonical pathway driving myofibroblast differentiation is driven by
  TGF-β-mediated Smad and MEK/Erk signaling14. However, upon binding to CXCR4, CXCL12
  promotes the transactivation of EGFR, potentially through MMP/ADAM as previously
  described by Kasina et.al in prostate cancer cells35 and Src activation, as shown
  in the supplementary data (). Active EGFR then activates Akt and MEK/ERK signaling
  pathways to promote myofibroblast marker gene expression and phenoconversion. CXCL12-mediated
  phenoconversion acts independently of TGFβR/Smad-mediated myofibroblast phenoconversion.
papertitle: CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion
  through Non-Canonical EGFR/MEK/ERK Signaling.
reftext: José A. Rodríguez-Nieves, et al. PLoS One. 2016;11(7):e0159490.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9613809
figid_alias: PMC4951124__F6
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Oryctolagus cuniculus
- Equus caballus
redirect_from: /figures/PMC4951124__F6
ndex: 33e6b385-dedc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4951124__pone.0159490.g006.html
  '@type': Dataset
  description: The canonical pathway driving myofibroblast differentiation is driven
    by TGF-β-mediated Smad and MEK/Erk signaling14. However, upon binding to CXCR4,
    CXCL12 promotes the transactivation of EGFR, potentially through MMP/ADAM as previously
    described by Kasina et.al in prostate cancer cells35 and Src activation, as shown
    in the supplementary data (). Active EGFR then activates Akt and MEK/ERK signaling
    pathways to promote myofibroblast marker gene expression and phenoconversion.
    CXCL12-mediated phenoconversion acts independently of TGFβR/Smad-mediated myofibroblast
    phenoconversion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - TGFB1
  - TGFB2
  - TGFB3
  - CXCL12
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CXCR4
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - SMAD3
  - SMAD4
  - AKT1
  - AKT2
  - AKT3
  - Egfr
  - Tgfb1
  - Cxcl12
  - Adam7
  - Cxcr4
  - Src
  - Pik3cg
  - Ephb1
  - Mapk1
  - Mapk3
  - Smad3
  - Smad4
  - Akt1
  - Ltbp1
  - Mdk
  - Pik3r1
  - Ephb2
---
